Massive amounts of patient data that could help shed light on the world’s most deadly diseases are now available through a precision medicine platform.

The American Heart Association Precision Medicine Platform, part of the AHA Institute for Precision Cardiovascular Medicine, is the only resource of its kind focused on cardiovascular diseases. The data platform was developed with Amazon Web Services.

Precision medicine supporters say one size does not fit all when it comes to medical care. The approach factors in a person’s genetics, environment and lifestyle habits to pinpoint the best way to prevent and treat heart disease and stroke, the world’s two leading causes of death.

Laura M. Stevens is an early adopter of the platform and anticipates it will make big data analyses quicker and easier.

“It’s a great foundation for implementing precision medicine and research in a clinical setting,” said Stevens, a predoctoral National Library of Medicine Fellow in the computational biosciences program at the University of Colorado Anschutz Medical School. “I can’t wait to see where this will take us as a research community.”

Data sharing is a critical part of the puzzle in treating and preventing heart failure, stroke, coronary artery disease, atrial fibrillation and other cardiovascular diseases, the AHA said. Data comes from clinical trials, long-running epidemiologic studies, registries and real-time health data acquired through wearable devices and technology.

Among those so far to contribute information to the secure platform are AstraZeneca, Cedars-Sinai Heart Institute, Dallas Heart Study, Duke Clinical Research Institute, Intermountain Health, the International Stroke Genetics Consortium, the National Heart, Lung, and Blood Institute, and Stanford University.

The AHA Institute for Precision Cardiovascular Medicine offers a variety of grant opportunities for scientists and researchers from many different fields of study.